Optinose Announces Reporting Date for Third Quarter 2024 Financial Results

Rhea-AI Summary

Optinose (NASDAQ:OPTN), a pharmaceutical company focused on ENT and allergy specialists, has scheduled its third quarter 2024 financial results announcement for Tuesday, November 12, 2024, before market open. The company will host a conference call at 8:00 a.m. Eastern Time on the same day, featuring its leadership team who will discuss financial results and corporate updates. Interested participants can join via webcast through the company's investor relations website or register for telephone access. A replay will be available for 60 days following the event.

News Market Reaction

+5.95%

1 alert

+5.95% News Effect

On the day this news was published, OPTN gained 5.95%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Conference Call and Webcast to be held November 12, 2024, at 8:00 a.m. Eastern Time

YARDLEY, Pa., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company will report financial results for the third quarter 2024 and corporate updates, before market open, on Tuesday, November 12, 2024.

Company to Host Conference Call
Members of the Company’s leadership team will host a conference call to discuss financial results and corporate updates. The call is scheduled to start at 8:00 a.m. Eastern Time on Tuesday, November 12, 2024.

Participants may access the conference call live via webcast by visiting the Investors section of Optinose’s website at http://ir.optinose.com/event-calendar. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a personal PIN that can be used to access the call. In addition, a replay of the webcast will be available on the Company website for 60 days following the event.

About Optinose
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on X and LinkedIn.

Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531

FAQ

When will Optinose (OPTN) report Q3 2024 earnings?

Optinose (OPTN) will report its third quarter 2024 financial results before market open on Tuesday, November 12, 2024.

What time is Optinose's (OPTN) Q3 2024 earnings call?

Optinose's Q3 2024 earnings conference call is scheduled for Tuesday, November 12, 2024, at 8:00 a.m. Eastern Time.

How can I access Optinose's (OPTN) Q3 2024 earnings call?

You can access the call via webcast through Optinose's investor relations website or register for telephone access through the provided registration link.

How long will Optinose's (OPTN) Q3 2024 earnings call replay be available?

The webcast replay will be available on the company's website for 60 days following the event.